Technology Networks - February 16, 2024
Xingxing Zang, Ph.D., says chimeric antigen receptor (CAR)-immune cell therapy, particularly CAR-T therapy, is a major advancing field with potential to revolutionize cancer treatment, particularly for leukemia and lymphoma. Dr. Zang is a member of the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC), and professor of microbiology & immunology, of oncology, of medicine, and of urology, and the Louis Goldstein Swan Chair in Cancer Research at Einstein.
Zang's Profile
CNN - February 9, 2024
Nir Barzilai, M.D., says 2024 presidential candidates Joe Biden and Donald Trump, whose parents lived over 90, may be aging more slowly than people who do not have longevity in their family. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
WNYC - February 1, 2024
Kathryn Anastos, M.D., recounts her work as an activist during the early days of the AIDS epidemic in New York City, and her efforts to educate others and push for studies about HIV and women. Dr. Anastos is professor of medicine, of epidemiology & population health, and of obstetrics & gynecology and women's health and associate director of global health at the Montefiore Einstein Comprehensive Cancer Center.
Dr. Anastos' Profile
ABC News - January 31, 2024
Lynne Holden, M.D., discusses a partnership between Einstein and Mentoring in Medicine that introduces Bronx high school students to careers in medicine and healthcare through hands-on EMT training. Dr. Holden is professor of emergency medicine and senior associate dean for diversity and inclusion at Einstein and an emergency medicine physician at Montefiore.
Dr. Holden's ProfileMore coverage on Dr. Holden
Newsweek - January 22, 2024
Qibin Qi, Ph.D., says findings of a new study he led about milk intake and diabetes risk can shed light on how milk affects human metabolic health. Dr. Qi is professor of epidemiology & population health and a member of the Montefiore Einstein Comprehensive Cancer Center.
Dr. Qi's ProfileMore coverage on Dr. Qi
OncLive - January 18, 2024
Susan Klugman, M.D., writes about Montefiore Einstein's leadership in educating patients and physicians about the importance of genetic testing, particularly for people who have a family history of cancer. Dr. Klugman is professor of pediatrics and of obstetrics & gynecology and women's health at Einstein, and director of reproductive and medical genetics at Montefiore.
Dr. Klugman's ProfileMore coverage on Dr. Klugman
Everyday Health - January 18, 2024
Brandilyn Peters-Samuelson, Ph.D., explains that higher estrogen in women is associated with greater microbial diversity, which is beneficial for their general health. Dr. Peters-Samuelson is assistant professor of epidemiology & population health at Einstein.
Dr. Peters-Samuelson's Profile
The New York Times - January 12, 2024
Nir Barzilai, M.D., says large, randomized controlled clinical trials are needed to determine if interventions purporting to promote longevity are effective. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Additional coverage includes The Guardian
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Today - January 4, 2024
Thomas Ullman, M.D., explains how he treats patients with ulcerative colitis and how they can manage their condition to minimize its effects. Dr Ullman is professor of medicine at Einstein, chief of the division of gastroenterology, and a gastroenterologist at Montefiore.
Dr. Ullman's Profile
MedPageToday - January 2, 2024
An opinion piece on artificial intelligence quotes an Einstein Doctor's Tablet blog by Simon Spivack, M.D., M.P.H., who writes that technology cannot replace the necessary human connection between patients and physicians. Dr. Spivack is professor of medicine, of epidemiology & population health, and of genetics at Einstein, and a pulmonologist at Montefiore.
Dr. Spivack's ProfileMore coverage on Dr. Spivack
Science News - December 8, 2023
Kerry Morrone, M.D., talks about the benefits of a new CRISPR treatment for sickle-cell disease and the importance of ensuring health equity for patients around the world who need treatment and care. Dr. Morrone is assistant professor of pediatrics at Einstein and director of the Sickle-Cell Program at the Children's Hospital at Montefiore.
Dr. Morrone's ProfileMore coverage on Dr. Morrone
The New York Times - December 5, 2023
Jelena Pavlovic, M.D., Ph.D., talks about the link between estrogen levels and migraine in women, noting that the start and timing of headaches for many women is connected with a drop in their estrogen, which occurs before and during menstruation. Dr. Pavolovic is associate professor in the Saul R. Korey Department of Neurology at Einstein and a neurologist at Montefiore.
Dr. Pavlovic's Profile
Live Science - December 1, 2023
Anjali Sharma, M.D., M.S., says access to antiretroviral therapy for HIV/AIDS, particularly for young people, and support systems for those on treatment are essential to ending the global AIDS epidemic. Dr. Sharma is professor of medicine at Einstein and an internist at Montefiore.
Dr. Sharma's Profile
NPR - November 29, 2023
Rahil Briggs, Psy.D., and Kevin Fiori, M.D., M.P.H., M.S., discuss the importance of HealthySteps, a program that supports low-income parents' psychological and social needs. Dr. Briggs is clinical professor of pediatrics and psychiatry & behavioral sciences at Einstein and national director of HealthySteps. Dr. Fiori is associate professor of pediatrics and of family & social medicine at Einstein and a pediatrician and director, social determinants of health, in the office of community & population health at Montefiore.
Dr. Briggs' ProfileMore coverage on Dr. Briggs
Dr. Fiori's Profile
Drug Discovery News - April 17, 2022
Nicholas Baker, Ph.D., discusses a study that discovered how epithelial cells interact with precancerous cells, recognizing them and removing them from the body. Dr. Baker is professor of genetics, of developmental and molecular biology, and of ophthalmology and visual sciences, and is the Harold and Muriel Block Chair in Genetics.
Dr. Baker's ProfileMore coverage on Dr. Baker
Healio - January 26, 2022
Tiffany Lu, M.D., M.S., describes her grant that will fund the expansion of addiction medicine and training programs for medical students and residents at Einstein and Montefiore. The curriculum will focus on the diagnosis and care for people with opioid use disorder, including guidance about medications for addiction treatment, particularly buprenorphine. Dr. Lu is assistant professor of medicine at Einstein and director of the Montefiore Buprenorphine Treatment Network.
Dr. Lu's Profile
Review of Ophthamology - October 10, 2021
Roy Chuck, M.D., Ph.D., describes the benefits of a new contact lens-like device, patented by Montefiore and Einstein, that is used in a treatment for keratoconus, an eye disease that affects the structure of the cornea. Dr. Chuck is professor and chair of ophthalmology and visual sciences and the Paul Henkind Chair in Ophthalmology at Einstein and Montefiore.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
Nature - September 2, 2020
In a commentary for Nature, Gary Schwartz, Ph.D., writes about the discovery of a pathway in the preoptic area of the brain in mice by which a light-sensitive protein regulates heat production. The findings may lead to ways of altering metabolism by manipulating environmental light. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.
Dr. Schwartz's ProfileMore coverage on Dr. Schwartz
Leukaemia Foundation MDS News - April 30, 2020
Ulrich Steidl, M.D., Ph.D., discusses his research on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and his hope that basic science and translational studies will lead to successful drug treatments for patients. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research and professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
Dr. Ovryn's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile